Open access
61
Views
26
CrossRef citations to date
0
Altmetric
Original Research
A randomized, parallel-group study to evaluate the efficacy of umeclidinium/vilanterol 62.5/25 μg on health-related quality of life in patients with COPD
Thomas M Siler1 Midwest Chest Consultants, PC, St Charles, MO, USACorrespondence[email protected]
, Alison C Donald2 GSK, Research Triangle Park, NC, USA
, Dianne O’Dell2 GSK, Research Triangle Park, NC, USA;3 Pearl Therapeutics, Inc., Durham, NC, USA
, Alison Church2 GSK, Research Triangle Park, NC, USA
& William A Fahy4 GSK, Respiratory Medicines Development Centre, Stockley Park, Middlesex, UK
Pages 971-979
|
Published online: 09 May 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.